Literature DB >> 16921126

State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice.

Jack A Elias1, Min Jong Kang, Kristina Crothers, Kristina Crouthers, Robert Homer, Chun Geun Lee.   

Abstract

Alveolar destruction is a cardinal feature of emphysema but is not traditionally believed to contribute to the pathogenesis of "classical" asthma. However, the relationship between chronic obstructive pulmonary disease (COPD) and asthma is controversial and the variety of mechanisms that can mediate the alveolar destruction in emphysema have not been adequately defined. To address these issues, we used overexpression transgenic approaches to define the effects of Th1/Tc1 and Th2/Tc2 cytokines in the mature murine lung and compared findings in these transgenic systems to the effects of similar interventions after cigarette smoke (CS) exposure. In these experiments, the Th1/Tc1 and Th2/Tc2 cytokines IFN-gamma and interleukin (IL)-13, respectively, both caused emphysema. The IFN-gamma response was associated with neutrophilia but was not associated with mucus metaplasia or a major fibrotic response. In this setting, IFN-gamma was a potent stimulator of matrix metalloproteinases (MMPs), cathepsins, and CXC and other chemokines while inhibiting secretory leukocyte proteinase inhibitor (SLPI). Interestingly, IFN-gamma induced its destructive effects via at least two mechanisms, a CCR5/cathepsin-dependent and apoptosis-mediated pathway and an MMP-12-dependent/apoptosis-independent pathway. CS-induced inflammation, apoptosis, and emphysema were also induced by IFN-gamma- and CCR5-dependent mechanisms. In contrast, IL-13-induced emphysema was associated with eosinophilia, mucus metaplasia, and pulmonary fibrosis. In this setting, IL-13 stimulated MMPs, cathepsins, and a variety of CC chemokines while inhibiting alpha(1)-antitrypsin. A cathepsin-dependent apoptosis pathway also contributed to this remodeling response. Interestingly, abnormalities in vascular endothelial growth factor (VEGF) were also appreciated with VEGF(165) excess producing an asthmalike pulmonary response and IFN-gamma abrogating this response while inducing emphysematous alveolar destruction. These findings provide molecular support for both points of view in the British/Dutch hypothesis controversy regarding the relationship between asthma and COPD. They also highlight the complexity of the pathways that can induce alveolar destruction and suggest that there is a continuum, based on VEGF, between asthma and COPD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16921126     DOI: 10.1513/pats.200603-068MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  31 in total

1.  A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity.

Authors:  M W Lethbridge; D M Kemeny; J C Ratoff; B J O'Connor; C M Hawrylowicz; C J Corrigan
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production.

Authors:  Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

Review 3.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

4.  Imbalance of apoptosis and cell proliferation contributes to the development and persistence of emphysema.

Authors:  Ji-Hyun Lee; Masayuki Hanaoka; Yoshiaki Kitaguchi; Donatas Kraskauskas; Leland Shapiro; Norbert F Voelkel; Laima Taraseviciene-Stewart
Journal:  Lung       Date:  2011-10-21       Impact factor: 2.584

5.  Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury.

Authors:  Simone Filosto; Sianna Castillo; Aaron Danielson; Lisa Franzi; Elaine Khan; Nick Kenyon; Jerold Last; Kent Pinkerton; Rubin Tuder; Tzipora Goldkorn
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

Review 6.  Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.

Authors:  Tzipora Goldkorn; Simone Filosto
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

7.  Chemokine receptor CXCR3 is important for lung tissue damage and airway remodeling induced by short-term exposure to cigarette smoking in mice.

Authors:  Li Nie; Zhen-jia Liu; Wei-xun Zhou; Ruo-lan Xiang; Yu Xiao; Bao Lu; Bao-sen Pang; Jin-ming Gao
Journal:  Acta Pharmacol Sin       Date:  2010-03-08       Impact factor: 6.150

8.  Elastin expression in very severe human COPD.

Authors:  G Deslee; J C Woods; C M Moore; L Liu; S H Conradi; M Milne; D S Gierada; J Pierce; A Patterson; R A Lewit; J T Battaile; M J Holtzman; J C Hogg; R A Pierce
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

9.  Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.

Authors:  Renat Shaykhiev; Anja Krause; Jacqueline Salit; Yael Strulovici-Barel; Ben-Gary Harvey; Timothy P O'Connor; Ronald G Crystal
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

10.  Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide.

Authors:  Irina Petrache; Terry R Medler; Amy T Richter; Krzysztof Kamocki; Ugonma Chukwueke; Lijie Zhen; Yuan Gu; Jeremy Adamowicz; Kelly S Schweitzer; Walter C Hubbard; Evgeny V Berdyshev; Giuseppe Lungarella; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-25       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.